Repositrak, INC Form 4 insider transactions

ReposiTrak's CEO, Randall K. Fields, executed sales of common stock under a pre-arranged Rule 10b5-1 trading plan to meet charitable commitments.

CEO Randall K. Fields sold shares of ReposiTrak, Inc. common stock on February 24 and 25, 2025, to meet charitable commitments under a pre-arranged Rule 10b5-1 trading plan.

ReposiTrak's CEO, Randall K. Fields, sold shares of common stock on February 18th and 19th, 2025, to meet charitable commitments under a pre-arranged Rule 10b5-1 trading plan.

ReposiTrak's CEO, Randall K. Fields, executed sales of common stock on February 10th and 11th, 2025, to fulfill charitable pledges through a pre-established Rule 10b5-1 trading plan.

ReposiTrak's CEO, Randall K. Fields, executed sales of common stock on February 3rd and 4th, 2025, under a pre-arranged Rule 10b5-1 trading plan.

ReposiTrak's CEO, Randall K. Fields, executed sales of common stock on January 27 and 28, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Director Robert Allen acquired 847 shares of ReposiTrak common stock on January 20, 2025, as compensation for board service.

Director Ronald Hodge acquired 847 shares of ReposiTrak, Inc. common stock on January 20, 2025, in lieu of cash payment for board service.

ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock at an average price of $21.6946, as part of a pre-arranged 10b5-1 trading plan.

ReposiTrak's CEO, Randall Fields, sold 7,500 shares of common stock at an average price of $20.5116 to fulfill charitable commitments under a pre-arranged Rule 10b5-1 trading plan.

ReposiTrak's CEO, Randall K. Fields, engaged in multiple stock transactions, including sales and transfers, under a pre-arranged 10b5-1 trading plan.

ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock at an average price of $21.8719 as part of a pre-arranged 10b5-1 trading plan.

ReposiTrak's CEO, Randall K. Fields, sold a total of 7,499 shares of common stock through a pre-arranged 10b5-1 trading plan to meet charitable commitments.

ReposiTrak CEO Randall Fields sold 7,500 shares of common stock at an average price of $24.4577 as part of a pre-arranged 10b5-1 trading plan.

Director Robert Allen of ReposiTrak, Inc. has increased his holdings through stock awards received in lieu of cash compensation for board service.

ReposiTrak director Ronald Hodge increased his holdings through stock awards for board service and the exercise of warrants.

ReposiTrak CEO Randall Fields sold a total of 7,490 shares of common stock through a pre-arranged 10b5-1 trading plan to meet charitable commitments.

ReposiTrak CEO Randall K. Fields sold a total of 7,500 shares of common stock through a pre-arranged 10b5-1 trading plan.

ReposiTrak CEO Randall K. Fields sold a total of 7,500 shares of common stock through a pre-arranged 10b5-1 trading plan to meet charitable commitments.

ReposiTrak's CEO, Randall K. Fields, sold a total of 7,500 shares of common stock through a pre-arranged 10b5-1 trading plan.

ReposiTrak's CEO, Randall K. Fields, sold a portion of his shares through a pre-arranged trading plan to meet charitable commitments.

ReposiTrak's CEO, Randall K. Fields, sold shares of common stock on November 4th and 5th, 2024, to meet charitable commitments under a pre-arranged Rule 10b5-1 trading plan.

ReposiTrak's CEO, Randall K. Fields, executed sales of common stock on October 28 and 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

ReposiTrak's CEO, Randall K. Fields, sold shares of common stock through a pre-arranged Rule 10b5-1 trading plan to meet charitable commitments.

Director Ronald Hodge acquired 1,873 shares of ReposiTrak, Inc. common stock on January 4, 2024, in lieu of cash compensation for board service.

Director Robert W. Allen acquired 1,873 shares of ReposiTrak, Inc. common stock on January 4, 2024, in lieu of cash payment for board service.